1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Lyophilisation for Pharmaceuticals: Products and Services 2015-2025 & Future Prospects for Leading Companies

Lyophilisation for Pharmaceuticals: Products and Services 2015-2025 & Future Prospects for Leading Companies

  • January 2015
  • -
  • Visiongain
  • -
  • 222 pages

Summary

Table of Contents

Please note: The license is valid for 12 months from the date the report is sent.


Report Details
What are the commercial prospects for pharmaceutical freeze-drying? Visiongain’s brand new report gives you revenue predictions for the lyophilisation for pharmaceuticals market and its submarkets to 2025, helping you stay ahead.

The 222-page report provides 142 tables, charts, and graphs. Discover the growing trends of this industry. In particular, our new study lets you assess forecasted sales at overall world market and national level. You will see financial results, drivers and restraints, and revenue predictions.

Besides revenue forecast to 2025, this report provides you with market shares, business outlooks, qualitative analyses (including SWOT, PESTEL Analysis and Porter’s Five Forces Analysis), company profiles and commercial developments. Also, read full transcripts of expert opinion interviews informing you about new lyophilisation technologies and the types of products that tend to be lyophilised:
- Dr Steven Nail, Principle Scientist, Baxter Medical Products R&D
-Enrico Corona, Formulation and Process Development Manager, Patheon Italia (Ferentino site)
-Scott Goldstein, Senior Manager at Fill-finish, Ajinomoto Althea

Discover sales predictions for the overall lyophilisation for pharmaceuticals market and the major Submarkets
In addition to analyses of the overall world market, you will see revenue forecasting of four world-level submarkets to 2025:
- cGMP lyophilisers
- Laboratory lyophilisers
- Lyophilisation services
- Others

This will give you insight into the leading Lyophilisation Products and Services market and their growth potential over the forecast period.

Find out the Prospects for Leading Therapeutic Applications
Also, you will see how eight drug classes using freeze drying technology will perform to 2025:
- Therapeutic monoclonal antibodies (mAbs)
- Insulins
- Interferons
- Other recombinant hormones
- Plasma and recombinant coagulation factors
- Biosimilars
- Vaccines
- Other therapeutic proteins

Our investigation shows business research and analysis with individual revenue forecasts and discussions. Use our predictions to help expand your business and you more influence. You will receive the forecasting leaders need.

What are the prospects in leading regions and countries?
The regional demand for lyophilisation products and services is expanding particularly in emerging markets. However, many commercial opportunities remain for lyophilisation technologies and services in developed countries as well.

Our analyses show you individual revenue forecasts to 2025 for 14 national markets:
- US
- Japan
- Germany
- France
- UK
- Italy
- Spain
- China
- Brazil
- Russia
- India
- Mexico
- South Korea
- Turkey
- RoW

New biological drugs and vaccines will benefit regional and national markets for those pharmaceutical drying technologies.

Leading companies and potential for market growth
Overall world revenue for the lyophilisation market will reach $3.45bn in 2015, our study forecasts. We predict greater demand for lyophilisation products and services over the forecast period, with equipment providers and CMOs providing lyophilisation services expanding to meet these market needs. Our work shows you which lyophilisation equipment and service providers hold greatest potential. See profiles of 12 leading companies:
- SP Scientific
- GEA Lyophil GmbH
- Labconco Corporation
- IIShinBioBase
- IMA Life
- Martin Christ Gefriertrocknungsanlagen GmbH
- Boehringer Ingelheim BioXcellence
- Pantheon
- Baxter BioPharma Solutions
- Recipharm
- IDT Biologika GmbH
- Vetter Pharma-Fertigung

In general, a company profile gives you the following information:
- Historical and recent financial results
- Discus

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.